Event info
Date:23 Jan - 30 Nov
Venue:Medicon Village, Lund, Sweden
Contact person
Sofia Norås

Sofia Norås

Project Manager

sn@mva.org

+45 2337 0040

MVA Oncology Network Meeting – Providing cutting-edge research and cancer care for the region

Medicon Valley Alliance, together with Lund University Cancer Center (LUCC) and Skåne University Hospital Comprehensive Cancer Centre (SUHCCC), has the pleasure of inviting you to the 13th MVA Oncology Network meeting.

In May 2022, Skåne University Hospital was accredited as a Comprehensive Cancer Centre (CCC). This demonstrates that SUHCCC is one of Europe’s leading cancer centers with highly competent staff and cutting-edge cancer treatments. This opens up new opportunities for both international and national collaborations.

The event will focus on how SUHCC and LUCC provide cancer care and manage research of the highest international quality based on patient needs, research-based therapies and innovations.

Please join us and learn about the successful research and care conducted in Lund that contribute to the oncology ecosystem in the Öresund region. We look forward to a discussion about further collaboration between academia, healthcare and industry within the field.

Date: 23rd of January, 2023
Time:
14.00 – 18.00
Venue:
Medicon Village, Hörsalen, Building Inspira, Scheelevägen 4, Lund 
Host and moderator:
LUCC

 

SIGN UP

Program:

14.00 – 14.30Registration and arrival
14.30 – 14.45Welcome and introduction 
Anette Steenberg, CEO, Medicon Valley Alliance
Sophia Zackrisson, Professor of Radiology, LUCC coordinator
14.45 – 15.05How a Comprehensive Cancer Centre designation may benefit clinical trial activities
Lisa Rydén, Professor, Senior Consultant Surgery, Skåne University Hospital, Lund
15.05 – 15.25    LUCC as a framework for stimulating translational cancer research, education and innovation in health care
Mef Nilbert, Professor, Senior Consultant, Skåne University Hospital, Lund
15.25 – 15.40Q&A
15.40 – 16.10Networking and refreshments
16.10 – 16.25Preclinical in vivo imaging for drug development
Ramin Massoumi , CEO, IVRS
16.25 – 16.40Targeting the Epitranscriptome
Sowndarya Muthukumar, CEO, SACRA Therapeutics
16.40 – 16.55Targeting a novel immune checkpoint on cancer stem cells
Carl Sandén, Co-founder, Lead Biologics
16.55 – 17.15  Q&A 
17.15 – 18.00Networking

Deadline for registration is 19th of January.

For more information please contact Sofia Norås sn@mva.org

The network

MVA Oncology Network is a professional and social network for professors, PIs and corporate level executives from the regional oncology eco-system. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region.

Joining the network is free of charge and is limited to Medicon Valley Alliance members only. However, non-member organizations and companies are welcome to attend one network event to evaluate if joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically allow you to join the oncology network.

Host and sponsor

 

In collaboration with
Lunduniversity logo